PTEN expression in breast and endometrial cancer: Correlations with steroid hormone receptor status

Pathobiology

Volumn 69, Issue 3, 2001, Pages 136-142

  Kappes, Holger ^a   Goemann, Christoph ^a   Bamberger, Ana Maria ^a   Löning, Thomas ^a   Milde Langosch, Karin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Breast cancer; Endometrial carcinoma; PTEN

Indexed keywords

ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PARAMETER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0035726273     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048768     Document Type: Article

References (17)

1. The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling
2. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
3. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
4. Mutational spectra of PTEN/MMAC1 gene: A tumor suppresor with lipid phosphatase activity
5. PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases
6. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
7. Mutation of PTEN/MMAC1 in mice causes neoplasia in multiple organ systems
8. Expression of cell cycle regulatory proteins Rb, p16/MTS1, p27/Kip1, p21/Waf1, cyclin D1 and cyclin E in breast cancer: Correlations with expression of activating protein-1 family members
9. Expression pattern of the AP-1 family in breast cancer: Association of fosB expression with a well-differentiated, receptor-positive phenotype
10. PTEN/MMAC1 mutations in endometrial cancers
11. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
12. Molecular identification of latent precancers in histologically normal endometrium
13. Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability
14. Cowden syndrome
15. Inactivation of the tumor suppressor gene PTEN/MMAC1 in advanced human prostate cancer through loss of expression
16. Changes in endometrial PTEN expression throughout the human menstrual cycle
17. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast